Growth hormone with anatagonist in low responders

Effect of addition of growth hormone with GnRH antagonist in women above 40: randomized control trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201306000461792

Enrollment

200

Registered

2012-11-22

Start date

2013-06-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Fertility-female low responders infertile female in ICSI

Interventions

Growth hormone

Conventional

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Regular cycle

Exclusion criteria

Exclusion criteria: 1. Antral follicle count (AFC) <4 2. Anti-mullarian hormone (AMH) <0.7 3. No response in a previous ICSI cycle

Design outcomes

Primary

Measure	Time frame
clinical pregnancy with cardiac pulsation	—

Secondary

Measure	Time frame
Number of ampoules of hMG;cycle cancellation;Aboration	—

Countries

Libyan Arab Jamahiriya

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026